CytomX Therapeutics
Patents, Design & Utilities

Last updated:

List of all CytomX Therapeutics patents 66 in total

Status Patent
Application
Utility: ANTI-CD166 ANTIBODIES AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 16 Jul 2020
Grant
Utility: Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 14 Jul 2020
Grant
Utility: Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 2 Jun 2020
Grant
Utility: Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 antibodies, and methods of using the same External link
Filling date: 8 Sep 2025 Issue date: 2 Jun 2020
Grant
Utility: Activatable antibodies that bind interleukin-6 receptor and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 7 Apr 2020
Grant
Utility: Antibodies that bind activatable antibodies and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 25 Feb 2020
Application
Utility: COMPOSITIONS AND METHODS FOR DETECTING PROTEASE ACTIVITY IN BIOLOGICAL SYSTEMS External link
Filling date: 8 Sep 2025 Issue date: 23 Jan 2020
Grant
Utility: Nucleic acids encoding activatable antibodies that bind epidermal growth factor receptor External link
Filling date: 8 Sep 2025 Issue date: 14 Jan 2020
Grant
Utility: Cleavage-activatable interferon-alpha proprotein External link
Filling date: 8 Sep 2025 Issue date: 24 Dec 2019
Grant
Utility: Anti-PD1 antibodies, activatable anti-PD1 antibodies, and methods of use thereof External link
Filling date: 8 Sep 2025 Issue date: 24 Dec 2019
Application
Utility: ANTI-PDL1 ANTIBODIES, ACTIVATABLE ANTI-PDL1 ANTIBODIES, AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 19 Dec 2019
Application
Utility: ANTI-JAGGED 1/JAGGED 2 CROSS-REACTIVE ANTIBODIES, ACTIVATABLE ANTI-JAGGED ANTIBODIES AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 5 Dec 2019
Application
Utility: Activatable Anti-CTLA-4 Antibodies and Uses Thereof External link
Filling date: 8 Sep 2025 Issue date: 28 Nov 2019
Application
Utility: ANTI-ITGA3 ANTIBODIES, ACTIVATABLE ANTI-ITGA3 ANTIBODIES, AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 10 Oct 2019
Application
Utility: MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 19 Sep 2019
Application
Utility: MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF External link
Filling date: 8 Sep 2025 Issue date: 8 Aug 2019

Showing 50 to 66 of 66 patents.